A Validated T Cell Radiomics Score Is Associated With Clinical Outcomes Following Multisite SBRT and Pembrolizumab
- 1 September 2020
- journal article
- research article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 108 (1), 189-195
- https://doi.org/10.1016/j.ijrobp.2020.06.026
Abstract
No abstract availableThis publication has 37 references indexed in Scilit:
- Statistical and Practical Considerations for Clinical Evaluation of Predictive BiomarkersJNCI Journal of the National Cancer Institute, 2013
- Up-Regulation of PD-L1, IDO, and T regs in the Melanoma Tumor Microenvironment Is Driven by CD8 + T CellsScience Translational Medicine, 2013
- Radiomics: the process and the challengesMagnetic Resonance Imaging, 2012
- Workflow-centred evaluation of an automatic lesion tracking software for chemotherapy monitoring by CTEuropean Radiology, 2012
- Oligometastases Treated With Stereotactic Body Radiotherapy: Long-Term Follow-Up of Prospective StudyInternational Journal of Radiation Oncology*Biology*Physics, 2011
- Stereotactic body radiotherapy for multisite extracranial oligometastasesCancer, 2011
- Gene Signature in Melanoma Associated With Clinical ActivityThe Cancer Journal, 2010
- Use of Archived Specimens in Evaluation of Prognostic and Predictive BiomarkersJNCI Journal of the National Cancer Institute, 2009
- Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell RecruitmentCancer Research, 2009
- Dangers of Using "Optimal" Cutpoints in the Evaluation of Prognostic FactorsJNCI Journal of the National Cancer Institute, 1994